WO2009017463A3 - NOVEL β-GLUCANS ISOLATED FROM HIGHER BASIDIOMYCETES MUSHROOM GANODERMA TSUGAE VAR. JANNIEAE - Google Patents

NOVEL β-GLUCANS ISOLATED FROM HIGHER BASIDIOMYCETES MUSHROOM GANODERMA TSUGAE VAR. JANNIEAE Download PDF

Info

Publication number
WO2009017463A3
WO2009017463A3 PCT/SG2008/000278 SG2008000278W WO2009017463A3 WO 2009017463 A3 WO2009017463 A3 WO 2009017463A3 SG 2008000278 W SG2008000278 W SG 2008000278W WO 2009017463 A3 WO2009017463 A3 WO 2009017463A3
Authority
WO
WIPO (PCT)
Prior art keywords
jannieae
var
novel
ganoderma tsugae
higher basidiomycetes
Prior art date
Application number
PCT/SG2008/000278
Other languages
French (fr)
Other versions
WO2009017463A2 (en
Inventor
Lee Chan Siew
Wasser Solomon P
Original Assignee
Hypha Holdings Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hypha Holdings Pte Ltd filed Critical Hypha Holdings Pte Ltd
Priority to SG2010054831A priority Critical patent/SG174111A1/en
Publication of WO2009017463A2 publication Critical patent/WO2009017463A2/en
Publication of WO2009017463A3 publication Critical patent/WO2009017463A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/271—Curdlan; beta-1-3 glucan; Polysaccharides produced by agrobacterium or alcaligenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Novel highly soluble in water β-glucan is provided that can be obtained from the fruiting bodies or the submerged cultivated mycelium biomass of the higher Basidiomycetes medicinal mushroom Ganoderma tsugae var. jannieae strain Tay-1. Also provided are compositions comprising the β-glucan for use as nutriceuticals, dietary supplements, cosmetic products, and in therapy.
PCT/SG2008/000278 2007-07-31 2008-07-30 NOVEL β-GLUCANS ISOLATED FROM HIGHER BASIDIOMYCETES MUSHROOM GANODERMA TSUGAE VAR. JANNIEAE WO2009017463A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG2010054831A SG174111A1 (en) 2007-07-31 2008-07-30 NOVEL ß-GLUCANS ISOLATED FROM HIGHER BASIDIOMYCETES MUSHROOM GANODERMA TSUGAE VAR. JANNIEAE

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95301107P 2007-07-31 2007-07-31
US60/953,011 2007-07-31

Publications (2)

Publication Number Publication Date
WO2009017463A2 WO2009017463A2 (en) 2009-02-05
WO2009017463A3 true WO2009017463A3 (en) 2009-05-07

Family

ID=40305080

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SG2008/000278 WO2009017463A2 (en) 2007-07-31 2008-07-30 NOVEL β-GLUCANS ISOLATED FROM HIGHER BASIDIOMYCETES MUSHROOM GANODERMA TSUGAE VAR. JANNIEAE

Country Status (2)

Country Link
SG (1) SG174111A1 (en)
WO (1) WO2009017463A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017173241A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
CA3043748A1 (en) 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
CN108969530A (en) * 2017-05-31 2018-12-11 三华生物科技股份有限公司 A kind of polysaccharide mixture is used to prepare the purposes of hyperglycemia drug

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1715298A (en) * 2004-06-29 2006-01-04 长春市恒泰生物技术有限公司 Ganodema tsugae-proteoglycan and its preparing method and use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1715298A (en) * 2004-06-29 2006-01-04 长春市恒泰生物技术有限公司 Ganodema tsugae-proteoglycan and its preparing method and use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BAO, XING-FENG ET AL.: "Structuralfeatures of immunologically active polysaccharides from Ganoderma lucidum", PHYTOCHEMISTRY, vol. 59, no. 2, 2002, pages 175 - 181 *
MIYAZAKI, TOSHIO ET AL.: "Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum", CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 29, no. 12, 1981, pages 3611 - 3616 *

Also Published As

Publication number Publication date
SG174111A1 (en) 2011-10-28
WO2009017463A2 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
Bak et al. Determination of glucan contents in the fruiting bodies and mycelia of Lentinula edodes cultivars
Sarangi et al. Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans
Choi et al. Physiological activities of extract from edible mushrooms
Poucheret et al. Biological and pharmacological activity of higher fungi: 20-year retrospective analysis
WO2008097482A3 (en) Mycellated grain and other myceliated agricultural materials to be used as animal food supplement
DK1483299T3 (en) Cell wall derivatives from biomass and their preparation
WO2007126727A8 (en) WATER SOLUBLE β-GLUCAN, GLUCOSAMINE, AND N-ACETYLGLUCOSAMINE COMPOSITIONS AND METHODS FOR MAKING THE SAME
WO2007067682A3 (en) In vivo cell surface engineering
Cruz et al. Health benefits of edible mushrooms focused on Coriolus versicolor: A review
Wang et al. Quorum sensing molecule-farnesol increased the production and biological activities of extracellular polysaccharide from Trametes versicolor
Liu et al. Immunoactivities and antineoplastic activities of Saccharomyces cerevisiae mannoprotein
WO2009017463A3 (en) NOVEL β-GLUCANS ISOLATED FROM HIGHER BASIDIOMYCETES MUSHROOM GANODERMA TSUGAE VAR. JANNIEAE
CN103340909B8 (en) Biological wall breaking method for ganoderma lucidum spore powder
WO2006027521A3 (en) Method of obtaining a firming active principle and active principle thus obtained
Nikitina et al. Lentinula edodes biotechnology–from lentinan to lectins
MY183349A (en) Use of lanostane and poria extract in treating diabetes
Üstün Makrofungusların besin değeri ve biyolojik etkileri
Kim et al. Submerged production and characterization of Grifola frondosa polysaccharides–a new application to cosmeceuticals
Jin et al. Extraction optimization and bioactivity of polysaccharides from Aspergillus fumigatus AF1
Pala et al. Mushrooms: The entities with multifarious medicinal properties
Milovanović et al. Effects of selenium presence in mycelia of Ganoderma species (higher basidiomycetes) on their medicinal properties
Jin et al. Extraction optimization and bioactivities of an extracellular polysaccharide produced by Aspergillus fumigatus
EP2508190A4 (en) Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages
Azelee et al. Mushroom Bioactive Ingredients in Cosmetic Industries
GB201017196D0 (en) Product

Legal Events

Date Code Title Description
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08826804

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 08826804

Country of ref document: EP

Kind code of ref document: A2